Ten years of NovoMix 30 in Russian and international clinical practice
Insulin treatment for type 2 diabetes mellitus is challenging in elderly people. Biphasic insulin preparations technically simplify this task, but also increase compliance and facilitate the achievement of therapeutic goals.
Saved in:
Main Author: | Elena Viktorovna Surkova |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/cd60a5d18b7d4f7481e31e3f4235ee25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
by: Elena Viktorovna Surkova
Published: (2013) -
Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
by: Yury Ivanovich Filippov, et al.
Published: (2012) -
Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014) -
Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
by: Dmitriy Nikitich Laptev, et al.
Published: (2013) -
Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: resultsfrom a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 inroutine clinical practice
by: Marina Vladimirovna Shestakova, et al.
Published: (2010)